Boston, MA 01/29/2014 (wallstreetpr) – Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) the Chinese online travelling services provider has had a mixed month thus far. First on the list which moved the stock prices northwards was the upgrade by JP Morgan in second week of January. The upgrade to Overweight, meant Ctrip.com International, Ltd. (NASDAQ:CTRP) moving by over 2.4%. Just was just after a week of downward movement following CLSA’s down grade along with UBS moving CRP stock to BUY.
The reasons for the early downgrade was based on the low-margins the company was operating on, in a bid to capture the mobile user base in terms of volume, besides competing with new entrant Qunar, in this league.
KB Home (NYSE:KBH) the residential construction major in US moved down on the stock markets following a downgrade by Barclays. The analyst chose to move KB Home (NYSE:KBH) to Underweight, resulting in the firm losing by over 4.7 %, by the end of trading day on January 27. However, Barclays’s move to upgrade Mertiage Home to Overweight did not help much as the company continued to move in the red. KBH has since reported dividend of $0.025 in line with previous payout. The forward yield is 0.55% and payable as of Feb 20 towards those shareholders owning until Feb 6.
Abbott Laboratories (NYSE:ABT) one of the better known names in healthcare products and drug manufacturers in the US, had not so good news to share on the fourth quarter news. The net profit sank abysmally by over 44% reporting $589 million. Though the EPS remained in-line at 0.58, the revenue miss was by over $70 million as the revenue it brought in was only $5.65 billion. In the meanwhile the company has chosen to bring in share repurchasing in 2014 to be higher than $2 billion. For 2014, Abbott Laboratories (NYSE:ABT) expects to have an adjusted EPS of $2.16 to $2.26. Estimated consensus is at $2.21
